IRELAND – AstraZeneca has announced that its rare disease group Alexion will invest €65 million (US$68.7M) to scale up its biologics manufacturing capacity and expand R&D efforts at its sites…
Read MoreTag: AstraZeneca
AstraZeneca and AmoyDx partner for multiple companion diagnostics
UNITED KINGDOM – AstraZeneca and China-based Amoy Diagnostics (AmoyDx) have signed a master collaboration agreement for multiple companion diagnostics programs in China, the EU, and Japan. The agreement allows both…
Read MoreGhana receives doses of AstraZeneca COVID-19 vaccine from Japan
GHANA – Ghana has received 309,600 doses of the AstraZeneca COVID-19 vaccine donated by the Japanese Government to support the ongoing mass COVID-19 vaccination exercise. The Deputy Minister of Health…
Read MoreEuropean drug watchdog backs AstraZeneca COVID-19 prevention jab
NETHERLANDS – The European Union’s drug watchdog has recommended for approval AstraZeneca’s Covid-19 prevention cocktail, which can be used for patients with immune system problems or severe reactions to other…
Read MoreAstraZeneca partners with Circular Bioeconomy Alliance (CBA) to plant over 3 million trees in Ghana
GHANA – AstraZeneca has announced a partnership with the Circular Bioeconomy Alliance (CBA) and local partners at the Global Forest Summit to establish the first ‘Living Lab’ by planting over…
Read MoreAstraZeneca forays into digital health in new pact with Huma Therapeutics
UNITED KINGDOM – According to a company press release, AstraZeneca invested approximately US$33 million in UK-based digital health startup Huma Therapeutics. As part of the agreement, Huma will acquire AstraZeneca’s…
Read MoreGlobal R&D challenge to accelerate scientific discovery and diversity
UNITED KINGDOM –AstraZeneca has announced the launch of a global R&D Postdoctoral Challenge to help accelerate ideas that will transform the treatment of some of the world’s most complex diseases.…
Read MoreAstraZeneca’s unit Alexion to pay Chugai US$775M to settle patent dispute
UNITED KINGDOM –AstraZeneca’s Alexion will pay US$775 million to Roche’s subsidiary, Chugai Pharmaceutical to resolve all patent disputes related to the C5 inhibitor Ultomiris (ravulizumab), the two companies have said.…
Read MoreAstraZeneca partners with oncologists, patient groups on ovarian cancer care
UNITED KINGDOM – AstraZeneca (AZ) has announced a new Ovarian Cancer Commitment (OCC) initiative aimed at improving survival and quality of life for women diagnosed with the disease. Fewer than…
Read MoreMerck’s bid to combine two top drugs for prostate cancer flops
USA – Merck & Co. has halted a Phase 3 trial testing a combination of two widely used cancer drugs, Keytruda and Lynparza, in patients with advanced prostate tumors due…
Read More